Events Partner Content 2nd Digital Exosome Based Therapeutic Development Summit Advancing the Success of Exosome Therapeutics
Partner Content Partner Content Attendee List Released for SMi’s 9th Annual RNA Therapeutics RNA Therapeutics
Partner Content Partner Content The first patient to be injected with an RNA based anti-canc... RNA Therapeutics
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
